
CORZ Valuation
Core Scientific Inc
- Overview
- Forecast
- Valuation
- Earnings
CORZ Relative Valuation
CORZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CORZ is overvalued; if below, it's undervalued.

Get winning stock picks in minutes
Historical Valuation
Core Scientific Inc (CORZ) is now in the Fair zone, suggesting that its current forward PS ratio of 6.67 is considered Fairly compared with the five-year average of -209.22. The fair price of Core Scientific Inc (CORZ) is between 7.70 to 16.85 according to relative valuation methord.
Relative Value
Fair Zone
7.70-16.85
Current Price:15.11
Fair
181.40
PE
1Y
3Y
5Y
Trailing
Forward
19.41
EV/EBITDA
Core Scientific Inc. (CORZ) has a current EV/EBITDA of 19.41. The 5-year average EV/EBITDA is 16.63. The thresholds are as follows: Strongly Undervalued below 4.05, Undervalued between 4.05 and 10.34, Fairly Valued between 22.92 and 10.34, Overvalued between 22.92 and 29.21, and Strongly Overvalued above 29.21. The current Forward EV/EBITDA of 19.41 falls within the Historic Trend Line -Fairly Valued range.
113.64
EV/EBIT
Core Scientific Inc. (CORZ) has a current EV/EBIT of 113.64. The 5-year average EV/EBIT is 18.57. The thresholds are as follows: Strongly Undervalued below -214.78, Undervalued between -214.78 and -98.11, Fairly Valued between 135.24 and -98.11, Overvalued between 135.24 and 251.92, and Strongly Overvalued above 251.92. The current Forward EV/EBIT of 113.64 falls within the Historic Trend Line -Fairly Valued range.
6.67
PS
Core Scientific Inc. (CORZ) has a current PS of 6.67. The 5-year average PS is 4.90. The thresholds are as follows: Strongly Undervalued below -0.15, Undervalued between -0.15 and 2.38, Fairly Valued between 7.43 and 2.38, Overvalued between 7.43 and 9.95, and Strongly Overvalued above 9.95. The current Forward PS of 6.67 falls within the Historic Trend Line -Fairly Valued range.
16.41
P/OCF
Core Scientific Inc. (CORZ) has a current P/OCF of 16.41. The 5-year average P/OCF is 15.08. The thresholds are as follows: Strongly Undervalued below -0.50, Undervalued between -0.50 and 7.29, Fairly Valued between 22.88 and 7.29, Overvalued between 22.88 and 30.67, and Strongly Overvalued above 30.67. The current Forward P/OCF of 16.41 falls within the Historic Trend Line -Fairly Valued range.
-106.72
P/FCF
Core Scientific Inc. (CORZ) has a current P/FCF of -106.72. The 5-year average P/FCF is 0.04. The thresholds are as follows: Strongly Undervalued below -83.97, Undervalued between -83.97 and -41.97, Fairly Valued between 42.04 and -41.97, Overvalued between 42.04 and 84.04, and Strongly Overvalued above 84.04. The current Forward P/FCF of -106.72 falls within the Strongly Undervalued range.
Core Scientific Inc (CORZ) has a current Price-to-Book (P/B) ratio of -4.14. Compared to its 3-year average P/B ratio of -5.76 , the current P/B ratio is approximately -28.20% higher. Relative to its 5-year average P/B ratio of -5.76, the current P/B ratio is about -28.20% higher. Core Scientific Inc (CORZ) has a Forward Free Cash Flow (FCF) yield of approximately -5.78%. Compared to its 3-year average FCF yield of 0.16%, the current FCF yield is approximately -3682.32% lower. Relative to its 5-year average FCF yield of 0.16% , the current FCF yield is about -3682.32% lower.
-4.14
P/B
Median3y
-5.76
Median5y
-5.76
-5.78
FCF Yield
Median3y
0.16
Median5y
0.16

Get winning stock picks in minutes
Competitors Valuation Multiple
The average P/S ratio for CORZ's competitors is 6.50, providing a benchmark for relative valuation. Core Scientific Inc Corp (CORZ) exhibits a P/S ratio of 6.67, which is 2.65% above the industry average. Given its robust revenue growth of -44.28%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CORZ increased by 46.41% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -570.44 to -1.19K.
The secondary factor is the P/E Change, contributed -18.17%to the performance.
Overall, the performance of CORZ in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

ASB
Associated Banc-Corp
24.740
USD
+3.47%

AX
Axos Financial Inc
88.050
USD
+4.31%

GSHD
Goosehead Insurance Inc
86.070
USD
-0.60%

AI
C3.ai Inc
16.910
USD
+2.67%

PRCT
Procept Biorobotics Corp
38.600
USD
-0.44%

OGS
ONE Gas Inc
75.850
USD
+0.96%

KMPR
Kemper Corp
52.270
USD
+2.61%

IBOC
International Bancshares Corp
70.910
USD
+3.10%

KGS
Kodiak Gas Services Inc
34.690
USD
+4.68%

UNF
UniFirst Corp
175.330
USD
+0.52%
FAQ

Is Core Scientific Inc (CORZ) currently overvalued or undervalued?
Core Scientific Inc (CORZ) is now in the Fair zone, suggesting that its current forward PS ratio of 6.67 is considered Fairly compared with the five-year average of -209.22. The fair price of Core Scientific Inc (CORZ) is between 7.70 to 16.85 according to relative valuation methord.

What is Core Scientific Inc (CORZ) fair value?

How does CORZ's valuation metrics compare to the industry average?

What is the current P/B ratio for Core Scientific Inc (CORZ) as of Aug 13 2025?

What is the current FCF Yield for Core Scientific Inc (CORZ) as of Aug 13 2025?

What is the current Forward P/E ratio for Core Scientific Inc (CORZ) as of Aug 13 2025?
